Oncology Letters · 2013 · 41 citations · 20 references
Life SciencesMolecular BiologyOncologyApoptosisGene ExpressionMolecular OncologyApoptosis RegulationCancer Stem CellsCell Cycle ControlCell Cycle Gene RegulationGene SilencingRna InterferenceCancer Cell ApoptosisCell Cycle Arrest MechanismsCell Cycle Control ProteinsCell Cycle InhibitionG2 Phase ProgressionG2 Phase RegulationRna Interference SuppressionStem Cell Marker Expression
Ubiquitin‑specific protease 22 (USP22) is a novel tumor stem cell marker that plays a key role in tumorigenesis and cell cycle progression. However, the effect of silencing the USP22 gene on human brain glioma cell growth is not well understood. In the present study, high gene expression of USP22 was identified in human brain glioma cells. In addition, RNA interference technology was used to silence USP22 gene expression in human brain glioma cells. Silencing the USP22 gene was found to effectively inhibit proliferation of human brain glioma cells, resulting in cell apoptosis and cell cycle arrest at the G2/M phase. USP22 silencing was also found to lead to reduced expression of cell cycle proteins, including CDK1, CDK2 and CyclinB1. In summary, in this study the USP22 gene was demonstrated to play a key regulatory role in the growth of human brain glioma cells by affecting progression of apoptosis and the cell cycle.
20
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Adult glioma incidence trends in the United States, 1977–2000
Kenneth R. Hess, Kristine Broglio, Melissa L. Bondy · Cancer · 2004 · 267 citations · Full text
Medicine, Biostatistics, Oncology +16